Xconomy’s Digital Events →
December 3, 2020 · New York
Cambridge, MA-based Editas Medicine is developing drugs using gene editing.
Xconomy Insight · Special Report
Industry experts explain what it takes to launch a new biotech company
Sponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.